Developer docs
API playgroundTry for free, no card

Search company profiles

Stratec

Full company profile

uuid000ll6e

Namestring
Stratec
Legal namestring
STRATEC SE
Websiteurl
stratec.com
Company typeenum
Public
Founded yearint
1979
Descriptiontext

STRATEC SE is a publicly listed German OEM developer and manufacturer of fully automated laboratory analyzer systems, software, and smart polymer-based consumables for the in-vitro diagnostics (IVD) and life sciences industries. Founded in 1979 and headquartered in Birkenfeld, Germany, the company operates an OEM partnership model in which it designs, develops, and manufactures customized mechatronic systems — covering liquid processing, pipetting, centrifugation, and microfluidics — that are distributed by diagnostics partners under their own brands. Major OEM partners include Roche, Siemens Healthineers, Hologic, BD, BioMérieux, DiaSorin, Grifols, and Werfen, alongside smaller collaborators such as Quanterix, Unchained Labs, and Cytovale.

The product portfolio rests on three integrated pillars: (1) STRATEC Instrumentation, comprising complete OEM analyzer systems and a proprietary technology pool of 12+ modules (LCM Pump, Peristaltic, Syringe, Piston pumps, Air/Liquid Displacement Pipettors, Degasser, Bulk Liquid Supply, Reagent Rack/Bay); (2) Consumables, leveraging photolithography mastering with feature sizes down to 150 nm, injection molding, coating, and bonding expertise originally derived from CD/DVD manufacturing and now consolidated across STRATEC Consumables GmbH (Austria) and Natech Plastics Inc. (USA); and (3) Software/Digital Solutions, centered on the Vigilant Online cloud IoT platform for fleet monitoring, remote troubleshooting, and FDA-aligned cybersecurity services (SBOM, secure token authentication, threat modeling). The Diatron subsidiary adds a branded direct-sales channel for hematology (Abacus, Aquila, Aquarius), clinical chemistry (P500, P700, P780), CLIA (KleeYa), and ELISA (GEMINI, FNX nova) analyzers, with over 40,000 hematology units in laboratory use globally.

STRATEC generates revenue through system sales, recurring consumables pull-through, lifecycle service contracts, and Diatron branded product sales, supported by six manufacturing sites across Germany, Switzerland, Hungary, China, Austria, and the USA, plus sales entities in the US and India. The company reported FY 2025 revenue of EUR 251 million (a 2.6% decline amid geopolitical and supply chain headwinds) and has publicly targeted a 13% EBIT margin by 2028 through new product launches and operational improvements, while continuing to distribute dividends (EUR 0.60 per share, EUR 7.3 million total in FY 2025).

Short descriptiontext

STRATEC SE is a German OEM manufacturer of fully automated analyzer systems, microfluidic consumables, and IoT software for in-vitro diagnostics and life sciences partners, including Roche, Siemens Healthineers, and Hologic.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBirkenfeld, Germany
HQ citystring
Birkenfeld
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
laboratory automation, in-vitro diagnostics, OEM analyzer systems, microfluidic consumables, clinical diagnostics instrumentation
Industry4 codes
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAH
Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters)
SECONDARYIMALAIAF
Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes)
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems
NAICS code4 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Laboratory Automation / IVD Instrumentation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Instrument Systems Sales
TypeHardware Sales
Description

Revenue from design, development, and manufacturing of fully automated analyzer systems sold to OEM diagnostic partners. Revenue model includes system sales as core component.

ad-hoc-news.de
2Consumables
TypeSubscription Recurring
Description

Smart polymer-based consumables including microfluidic chips and diagnostic consumables. Consumables complement instrumentation and software portfolio.

stratec.com
3Service Contracts
TypeSubscription Recurring
Description

Service contracts with major diagnostics partners providing ongoing revenue stream. Includes lifecycle management, third-level technical support, improvement services, and regulatory compliance support.

ad-hoc-news.de
4Diatron Brand Products
TypeHardware Sales
Description

Ready-made products and platforms under Diatron brand including CLIA analyzers (KleeYa), ELISA platforms (GEMINI, FNX nova), Hematology analyzers (Aquarius 3, Aquila, Abacus 5, Abacus 380), Clinical Chemistry analyzers (P500, P700, P780), and associated reagents, controls and calibrators.

stratec.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Diatron
Description

A STRATEC brand offering hematology analyzers (Aquarius 3, Aquila, Abacus 5, Abacus 380, Abacus Vet5), clinical chemistry analyzers (P500, Pictus 700, P780), CLIA analyzers (KleeYa), ELISA platforms (GEMINI, FNX nova), and associated reagents, controls, and calibrators.

stratec.com
+3 more records
Core offering1 text field

STRATEC designs and manufactures fully automated analyzer systems, software, and smart polymer-based consumables for OEM partners in clinical diagnostics and life sciences. The product portfolio spans OEM instrumentation from point-of-care to floor-standing analyzers, microfluidic consumables manufactured via photolithography and precision molding, and digital/IoT solutions (Vigilant Online) for fleet management, complemented by Diatron-branded ready-made analyzers for hematology, clinical chemistry, ELISA, and CLIA applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 40,000 hematology analyzers in laboratory use globally under Diatron brand
+1 more record
Product overview1 text field

Stratec designs and manufactures fully automated analyzer systems, software, and smart consumables for OEM partners in clinical diagnostics and life sciences. The product portfolio comprises three integrated pillars: (1) STRATEC Instrumentation — complete OEM analyzer systems and 12 proprietary modules (pipettors, pumps, degasser, liquid handling components) developed in-house; (2) Consumables — smart polymer-based microfluidic consumables leveraging photolithography, injection molding, coating, and bonding expertise derived from CD/DVD manufacturing; and (3) Software/Digital Solutions — Vigilant Online IoT platform for fleet management, plus cybersecurity services (SBOM, secure token authentication, OS security updates). The Diatron subsidiary (acquired) adds standalone branded instruments in Hematology (Abacus 380, Abacus 5, Aquila, Aquarius 3, Abacus Vet5), Clinical Chemistry (P500, P700, P780/Pictus), and Immunodiagnostics (KleeYa CLIA, GEMINI/FNX nova ELISA platforms). Stratec operates manufacturing sites in Germany, Switzerland, Hungary, and China for instrumentation, and Austria and the USA (Natech) for consumables.

Product and service3 records
1STRATEC Instrumentation (OEM Systems)
CategoryOEM Instrumentation
Description

Complete automated analyzer systems and instruments developed and manufactured for OEM partners in in-vitro diagnostics and life sciences, ranging from point-of-care to benchtop and floor-standing analyzers.

2STRATEC Consumables (Microfluidics)
CategoryMicrofluidic Consumables
Description

Smart polymer-based microfluidic consumables manufactured using photolithography, injection molding, coating, and bonding processes for IVD and life science applications.

3Vigilant Online (IoT Platform)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-01
Description

Acquisition of Natech Plastics, Inc., a manufacturer of smart polymer-based consumables based in Ronkonkoma, NY, USA. Completed July 1, 2023. Expands STRATEC's presence in the US market and adds a local production site. Aims to leverage synergies in sales and technology, and expand into new target markets. Natech has advanced production capabilities including clean room facilities and ISO 9001 & ISO 13485 certifications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Major IVD company and STRATEC OEM customer; operates in microbiology, immunoassay, and molecular diagnostics with significant automation needs — comparable end-market exposure and partially overlapping product adjacency.

2Beckman Coulter (Danaher)
TypeBroad incumbent
Description

Large diagnostics incumbent within Danaher offering clinical chemistry, immunoassay, hematology, and laboratory automation — overlaps with STRATEC's Diatron-branded hematology/clinical chemistry portfolio and overall IVD focus.

TypeOthers
Description

Major IVD/imaging customer of STRATEC with a large central laboratory automation footprint (Atellica, ADVIA Centaur) — directly comparable in IVD market but as a customer and channel rather than direct competitor.

TypeEmerging player
Description

German-headquartered manufacturer of liquid handling, pipettes, and lab automation consumables — overlaps with STRATEC's pipetting modules, consumables, and OEM offerings in adjacent life science segments.

TypeBroad incumbent
Description

Diversified life sciences and diagnostics company offering IVD reagents, analytical instruments, and laboratory automation — overlaps with STRATEC's OEM instrumentation and consumables business model.

TypeEmerging player
Description

Chinese IVD and medical device manufacturer growing internationally in hematology, clinical chemistry, and immunoassay analyzers — emerging competitor to Diatron-branded analyzers in mid-market and emerging markets.

TypeDirect peer
Description

Privately held US manufacturer of automated liquid handling workstations, pipetting robots, and OEM instrument platforms for IVD and life science applications — closely overlaps with STRATEC's pipetting/liquid handling and OEM focus.

TypeBroad incumbent
Description

Large analytical instrument manufacturer serving life sciences and clinical markets with chromatography, mass spectrometry, and lab automation — comparable to STRATEC's analytical instrumentation and OEM life science activities.

TypeBroad incumbent
Description

Global leader in hematology and IVD analyzers with a strong installed base of automated hematology instruments — directly comparable to Diatron's hematology franchise and broader IVD market overlap.

TypeDirect peer
Description

Swiss-listed OEM partner that develops and manufactures laboratory automation instruments, pipetting systems, and consumables for IVD and life science companies — directly comparable to STRATEC's OEM business model and customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stratec

Laboratory Automation / IVD Instrumentationstratec.com

STRATEC SE is a German OEM manufacturer of fully automated analyzer systems, microfluidic consumables, and IoT software for in-vitro diagnostics and life sciences partners, including Roche, Siemens Healthineers, and Hologic.

What Stratec does

STRATEC SE is a publicly listed German OEM developer and manufacturer of fully automated laboratory analyzer systems, software, and smart polymer-based consumables for the in-vitro diagnostics (IVD) and life sciences industries. Founded in 1979 and headquartered in Birkenfeld, Germany, the company operates an OEM partnership model in which it designs, develops, and manufactures customized mechatronic systems — covering liquid processing, pipetting, centrifugation, and microfluidics — that are distributed by diagnostics partners under their own brands. Major OEM partners include Roche, Siemens Healthineers, Hologic, BD, BioMérieux, DiaSorin, Grifols, and Werfen, alongside smaller collaborators such as Quanterix, Unchained Labs, and Cytovale.

The product portfolio rests on three integrated pillars: (1) STRATEC Instrumentation, comprising complete OEM analyzer systems and a proprietary technology pool of 12+ modules (LCM Pump, Peristaltic, Syringe, Piston pumps, Air/Liquid Displacement Pipettors, Degasser, Bulk Liquid Supply, Reagent Rack/Bay); (2) Consumables, leveraging photolithography mastering with feature sizes down to 150 nm, injection molding, coating, and bonding expertise originally derived from CD/DVD manufacturing and now consolidated across STRATEC Consumables GmbH (Austria) and Natech Plastics Inc. (USA); and (3) Software/Digital Solutions, centered on the Vigilant Online cloud IoT platform for fleet monitoring, remote troubleshooting, and FDA-aligned cybersecurity services (SBOM, secure token authentication, threat modeling). The Diatron subsidiary adds a branded direct-sales channel for hematology (Abacus, Aquila, Aquarius), clinical chemistry (P500, P700, P780), CLIA (KleeYa), and ELISA (GEMINI, FNX nova) analyzers, with over 40,000 hematology units in laboratory use globally.

STRATEC generates revenue through system sales, recurring consumables pull-through, lifecycle service contracts, and Diatron branded product sales, supported by six manufacturing sites across Germany, Switzerland, Hungary, China, Austria, and the USA, plus sales entities in the US and India. The company reported FY 2025 revenue of EUR 251 million (a 2.6% decline amid geopolitical and supply chain headwinds) and has publicly targeted a 13% EBIT margin by 2028 through new product launches and operational improvements, while continuing to distribute dividends (EUR 0.60 per share, EUR 7.3 million total in FY 2025).

Stratec firmographics

Firmographics
Name
Stratec
Legal name
STRATEC SE
Website
https://stratec.com
Company type
Public
Founded year
1979
Operating status
Operating
Headcount range
501–1,000 employees
Short description
STRATEC SE is a German OEM manufacturer of fully automated analyzer systems, microfluidic consumables, and IoT software for in-vitro diagnostics and life sciences partners, including Roche, Siemens Healthineers, and Hologic.
Ownership category
akta.pro rank

Stratec industry classification

Industry
Product category
Laboratory Automation / IVD Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAH
Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters)
SECONDARYIMALAIAF
Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes)
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems

Keywords

  • Laboratory automation
  • In-vitro diagnostics
  • OEM analyzer systems
  • Microfluidic consumables
  • Clinical diagnostics instrumentation

Where Stratec is headquartered

Location

Headquarters

HQ city
Birkenfeld
HQ country
Germany
HQ region
Europe

Offices9 records

Markets served

Stratec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Instrument Systems Sales: Revenue from design, development, and manufacturing of fully automated analyzer systems sold to OEM diagnostic partners. Revenue model includes system sales as core component.
  2. Consumables: Smart polymer-based consumables including microfluidic chips and diagnostic consumables. Consumables complement instrumentation and software portfolio.
  3. Service Contracts: Service contracts with major diagnostics partners providing ongoing revenue stream. Includes lifecycle management, third-level technical support, improvement services, and regulatory compliance support.
  4. Diatron Brand Products: Ready-made products and platforms under Diatron brand including CLIA analyzers (KleeYa), ELISA platforms (GEMINI, FNX nova), Hematology analyzers (Aquarius 3, Aquila, Abacus 5, Abacus 380), Clinical Chemistry analyzers (P500, P700, P780), and associated reagents, controls and calibrators.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Stratec product offering

Product offering

Core offering

STRATEC designs and manufactures fully automated analyzer systems, software, and smart polymer-based consumables for OEM partners in clinical diagnostics and life sciences. The product portfolio spans OEM instrumentation from point-of-care to floor-standing analyzers, microfluidic consumables manufactured via photolithography and precision molding, and digital/IoT solutions (Vigilant Online) for fleet management, complemented by Diatron-branded ready-made analyzers for hematology, clinical chemistry, ELISA, and CLIA applications.

Product overview

Stratec designs and manufactures fully automated analyzer systems, software, and smart consumables for OEM partners in clinical diagnostics and life sciences. The product portfolio comprises three integrated pillars: (1) STRATEC Instrumentation — complete OEM analyzer systems and 12 proprietary modules (pipettors, pumps, degasser, liquid handling components) developed in-house; (2) Consumables — smart polymer-based microfluidic consumables leveraging photolithography, injection molding, coating, and bonding expertise derived from CD/DVD manufacturing; and (3) Software/Digital Solutions — Vigilant Online IoT platform for fleet management, plus cybersecurity services (SBOM, secure token authentication, OS security updates). The Diatron subsidiary (acquired) adds standalone branded instruments in Hematology (Abacus 380, Abacus 5, Aquila, Aquarius 3, Abacus Vet5), Clinical Chemistry (P500, P700, P780/Pictus), and Immunodiagnostics (KleeYa CLIA, GEMINI/FNX nova ELISA platforms). Stratec operates manufacturing sites in Germany, Switzerland, Hungary, and China for instrumentation, and Austria and the USA (Natech) for consumables.

Differentiator

Problem solved

Functional benefit

Brands

  • Diatron: A STRATEC brand offering hematology analyzers (Aquarius 3, Aquila, Abacus 5, Abacus 380, Abacus Vet5), clinical chemistry analyzers (P500, Pictus 700, P780), CLIA analyzers (KleeYa), ELISA platforms (GEMINI, FNX nova), and associated reagents, controls, and calibrators.
  • Natech
  • Vigilant Online
  • Protowerk

Products and services

  • STRATEC Instrumentation (OEM Systems) Complete automated analyzer systems and instruments developed and manufactured for OEM partners in in-vitro diagnostics and life sciences, ranging from point-of-care to benchtop and floor-standing analyzers.
  • STRATEC Consumables (Microfluidics) Smart polymer-based microfluidic consumables manufactured using photolithography, injection molding, coating, and bonding processes for IVD and life science applications.
  • Vigilant Online (IoT Platform)

Quantifiable outcome

  • Over 40,000 hematology analyzers in laboratory use globally under Diatron brand
  • +1 more outcomes

Companies that use Stratec

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles2 records

Stratec technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Stratec partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Natech Plastics, Inc.coreStrategic or Co-development Partner · 1 July 2023Acquisition of Natech Plastics, Inc., a manufacturer of smart polymer-based consumables based in Ronkonkoma, NY, USA. Completed July 1, 2023. Expands STRATEC's presence in the US market and adds a local production site. Aims to leverage synergies in sales and technology, and expand into new target markets. Natech has advanced production capabilities including clean room facilities and ISO 9001 & ISO 13485 certifications.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Stratec competitors and assessment

Company assessment

Others

  • bioMérieux: Major IVD company and STRATEC OEM customer; operates in microbiology, immunoassay, and molecular diagnostics with significant automation needs — comparable end-market exposure and partially overlapping product adjacency.
  • Siemens Healthineers: Major IVD/imaging customer of STRATEC with a large central laboratory automation footprint (Atellica, ADVIA Centaur) — directly comparable in IVD market but as a customer and channel rather than direct competitor.

Broad incumbents

  • Beckman Coulter (Danaher): Large diagnostics incumbent within Danaher offering clinical chemistry, immunoassay, hematology, and laboratory automation — overlaps with STRATEC's Diatron-branded hematology/clinical chemistry portfolio and overall IVD focus.
  • Revvity (formerly PerkinElmer): Diversified life sciences and diagnostics company offering IVD reagents, analytical instruments, and laboratory automation — overlaps with STRATEC's OEM instrumentation and consumables business model.
  • Agilent Technologies: Large analytical instrument manufacturer serving life sciences and clinical markets with chromatography, mass spectrometry, and lab automation — comparable to STRATEC's analytical instrumentation and OEM life science activities.
  • Sysmex Corporation: Global leader in hematology and IVD analyzers with a strong installed base of automated hematology instruments — directly comparable to Diatron's hematology franchise and broader IVD market overlap.

Emerging players

  • Eppendorf: German-headquartered manufacturer of liquid handling, pipettes, and lab automation consumables — overlaps with STRATEC's pipetting modules, consumables, and OEM offerings in adjacent life science segments.
  • Mindray: Chinese IVD and medical device manufacturer growing internationally in hematology, clinical chemistry, and immunoassay analyzers — emerging competitor to Diatron-branded analyzers in mid-market and emerging markets.

Direct peers

  • Hamilton Company: Privately held US manufacturer of automated liquid handling workstations, pipetting robots, and OEM instrument platforms for IVD and life science applications — closely overlaps with STRATEC's pipetting/liquid handling and OEM focus.
  • Tecan Group: Swiss-listed OEM partner that develops and manufactures laboratory automation instruments, pipetting systems, and consumables for IVD and life science companies — directly comparable to STRATEC's OEM business model and customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Stratec social profiles

Digital presence

Stratec compliance and trust

Trust signal

Compliance8 records

Stratec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stratec leadership team

Management profile

Number of profiles

Profiles6 records

Stratec subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Stratec funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stratec M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stratec

What does Stratec do?

STRATEC designs and manufactures fully automated analyzer systems, software, and smart polymer-based consumables for OEM partners in clinical diagnostics and life sciences. The product portfolio spans OEM instrumentation from point-of-care to floor-standing analyzers, microfluidic consumables manufactured via photolithography and precision molding, and digital/IoT solutions (Vigilant Online) for fleet management, complemented by Diatron-branded ready-made analyzers for hematology, clinical chemistry, ELISA, and CLIA applications.

Is Stratec a public or private company?

Stratec is a public company. It is classified as public and is currently operating.

When was Stratec founded?

Stratec was founded in 1979. It employs 501 to 1,000 people.

Where is Stratec based?

Stratec is headquartered in Birkenfeld, Germany, in the Europe region.

How does Stratec make money?

Four revenue lines are on record. Instrument Systems Sales are the primary driver. The others are consumables, service Contracts and diatron Brand Products.

Who are Stratec's main competitors?

Others on record are bioMérieux and Siemens Healthineers. Broad incumbents are Beckman Coulter (Danaher), Revvity (formerly PerkinElmer), Agilent Technologies and Sysmex Corporation. Emerging players are Eppendorf and Mindray. Direct peers are Hamilton Company and Tecan Group.

Does Stratec have an API?

No public API is recorded for Stratec.

What industry is Stratec in?

Stratec's product category is Laboratory Automation / IVD Instrumentation. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAIAH, Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewSBS: Adjusted EBIT rose 6.5% in 9M as the outlook targets a 13.0%–15.0% FY marginStratec SE reported 9-month sales down 5% at constant currency, while adjusted EBIT rose 6.5% and operating cash flow reached €39.4m. The company guided FY2026 continuing-operations sales to stable or slightly higher and adjusted EBIT margin to 13.0%–15.0%.Simply Wall StStratec SE (ETR:SBS) Just Reported Half-Year Earnings And Analysts Are Lifting Their EstimatesStratec SE reported half-year revenue of €113m, beating forecasts by 3.2%, and shares rose 12% to €27.90. Analysts raised 2026 revenue estimates to €237.7m but kept the loss per share at €3.25, with no change to the consensus price target. The company's revenue decline is expected to moderate, though still worse than the industry's 5.6% growth.Seeking AlphaStratec SE (STSEY) Q3 2026 Earnings Call Prepared Remarks TranscriptStratec SE reported double-digit growth in its core molecular and immunoassay blood bank systems and complex sample prep platforms over the first nine months of 2026. The company also discussed the Diatron transaction and provided a financial review of the nine-month and third-quarter figures, followed by an outlook.MarketScreenerOil price decline keeps DAX stable, US election in focusOil prices fell on Iran-Qatar talks, keeping the DAX stable. Stratec shares rose nearly 3% on strong results, while energy-sensitive tech stocks recovered. Investors await Apple's results after US trading.FinanzNachrichten.deSTRATEC verkauft Verlustgeschäft - 44 Millionen Euro werden abgeschriebenSTRATEC sold its loss-making Diatron MI subsidiary to an Indian investor consortium, separating a loss-making business. The fixed purchase price is €10 million, with possible earn-out payments. The sold business includes products for hematology and clinical chemistry.The future of tradingGermany's Stratec to sell unit Diatron MI; lifts 2026 adjusted operating marginStratec will sell its loss-making Diatron MI unit for €10 million plus earn-outs, and will book a €44.1 million impairment in Q3. The company expects 2026 adjusted EBIT margin of 13-15% after divestment, up from 10%, and has withdrawn its medium-term targets.FinanzNachrichten.deEQS-Adhoc: STRATEC SE: STRATEC VERKAUFT VERLUSTBRINGENDEN GESCHÄFTSBEREICH, NIMMT WERTMINDERUNGEN VOR UND PASST AUSBLICK ANSTRATEC SE agreed to sell its Diatron MI subsidiary, covering hematology and clinical chemistry products, to an Indian consortium for €10 million plus earn-outs. The deal, expected in Q4 2026, will trigger €44.1 million in impairment charges and a €4-9 million deconsolidation effect. The board revised its 2026 outlook to a 13-15% adjusted EBIT margin.TradingViewSTRATEC SE (SBS) Sells Diatron For €10M, Books €44.1M Impairment, Lifts 2026 Margin OutlookSTRATEC SE agreed to sell Diatron MI for €10M with earn-outs, recording €44.1M non-cash impairments and a €4-9M deconsolidation effect. The company raised its 2026 adjusted EBIT margin guidance to 13-15% on stable sales, citing a focus on margins over growth.TradingViewSTRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCESTRATEC SE agreed to sell its Diatron MI subsidiary to Indian investors for €10 million, with earn-outs and expected Q4 2026 closing. The loss-making business is projected to generate €20 million in sales and minus €10 million in adjusted EBIT, triggering €44.1 million in impairments. STRATEC amended its 2026 guidance, forecasting an adjusted EBIT margin of 13-15%.FinanzNachrichten.deStratec SE: Verkaufsthese weitgehend aufgegangen; Umsetzungsrisiken bleiben bestehen; Hochstufung auf HALTENSTRATEC's stock has corrected significantly since the latest downgrade, reflecting valuation risks. The analyst upgraded the rating to HOLD and raised the price target to EUR 22 from EUR 21, citing a balanced risk-reward ratio. The upcoming 9M results on November 12 will test the sustainability of operational recovery.